Zhenya Wang

Prof. Dr. Zhenya Wang


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in Viruses
Verified
Journal Article
Open access
PDF file
HZHui-Hua Zheng
Hui-Hua Zheng
PFPeng-Fei Fu
Peng-Fei Fu
HCHongying Chen
Hongying Chen
ZWZhenya Wang
Zhenya Wang
Pseudorabies (PR), also called Aujeszky’s disease (AD), is a highly infectious viral disease which is caused by pseudorabies virus (PRV). It has been nearly 200 years since the first PR case occurred. Currently, the virus can infect human beings and various mammals, including pigs, sheep, dogs, rabbits, rodents, cattle and cats, and among them, pigs are the only natural host of PRV infection. PRV is characterized by reproductive failure in pregnant sows, nervous disorders in newborn piglets, and respiratory distress in growing pigs, resulting in serious economic losses to the pig industry worldwide. Due to the extensive application of the attenuated vaccine containing the Bartha-K61 strain, PR was well controlled. With the variation of PRV strain, PR re-emerged and rapidly spread in some countries, especially China. Although researchers have been committed to the design of diagnostic methods and the development of vaccines in recent years, PR is still an important infectious disease and is widely prevalent in the global pig industry. In this review, we introduce the structural composition and life cycle of PRV virions and then discuss the latest findings on PRV pathogenesis, following the molecular characteristic of PRV and the summary of existing diagnosis methods. Subsequently, we also focus on the latest clinical progress in the prevention and control of PRV infection via the development of vaccines, traditional herbal medicines and novel small RNAs. Lastly, we provide an outlook on PRV eradication.

16 June 2023 in Science Advances
Verified
Journal Article
Open access
NYNa Yin
Na Yin
ZZZhongmou Zhang
Zhongmou Zhang
YGYongzhuang Ge
Yongzhuang Ge
YZYuzhen Zhao
Yuzhen Zhao
ZGZichen Gu
Zichen Gu
ZWZhenya Wang
Zhenya Wang
Viral infections continue to threaten human health. It remains a major challenge to efficiently inhibit viral infection while avoiding secondary injury. Here, we designed a multifunctional nanoplatform (termed as ODCM), prepared by oseltamivir phosphate (OP)–loaded polydopamine (PDA) nanoparticles camouflaged by the macrophage cell membrane (CM). OP can be efficiently loaded onto the PDA nanoparticles through the π-π stacking and hydrogen bonding interactions with a high drug-loading rate of 37.6%. In particular, the biomimetic nanoparticles can accumulate actively in the damaged lung model of viral infection. At the infection site, PDA nanoparticles can consume excess reactive oxygen species and be simultaneously oxidized and degraded to achieve controlled release of OP. This system exhibits enhanced delivery efficiency, inflammatory storm suppression, and viral replication inhibition. Therefore, the system exerts outstanding therapeutic effects while improving pulmonary edema and protecting lung injury in a mouse model of influenza A virus infection.

14 February 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASAvishak Sarker
Avishak Sarker
ZGZichen Gu
Zichen Gu
LMLu Mao
Lu Mao
YGYongzhuang Ge
Yongzhuang Ge
DHDuoduo Hou
Duoduo Hou
ZWZhenya Wang
Zhenya Wang

28 June 2023 in Phytomedicine
Verified
Journal Article
Closed access
XLXiaojie Liu
Xiaojie Liu
LLLu Liu
Lu Liu
XWXu Wang
Xu Wang
YJYubin Jin
Yubin Jin
SWShuang Wang
Shuang Wang
CJCheng-Yun Jin
Cheng-Yun Jin

1 November 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XHXiangyu Huo
Xiangyu Huo
DHDuoduo Hou
Duoduo Hou
HWHaixia Wang
Haixia Wang
BHBin He
Bin He
JFJieyu Fang
Jieyu Fang
FLFeng-Wu Liu
Feng-Wu Liu

1 February 2020 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
LZLan-Lan Zheng
Lan-Lan Zheng
LCLv-Ye Chai
Lv-Ye Chai
RTRun-Bo Tian
Run-Bo Tian
YZYu Zhao
Yu Zhao
HCHongying Chen
Hongying Chen
ZWZhenya Wang
Zhenya Wang